Related Experiment Video
Updated: Jun 23, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic
Chiara Gerhardinger1, Zeina Dagher, Paola Sebastiani
1Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. chiara.gerhardinger@schepens.harvard.edu
Objective:
Prevention of diabetic retinopathy would benefit from availability of drugs that preempt the effects of hyperglycemia on retinal vessels. We aimed to identify candidate drug targets by investigating the molecular effects of drugs that prevent retinal capillary demise in the diabetic rat.
Research Design And Methods:
We examined the gene expression profile of retinal vessels isolated from rats with 6 months of streptozotocin-induced diabetes and compared it with that of control rats. We then tested whether the aldose reductase inhibitor sorbinil and aspirin, which have different mechanisms of action, prevented common molecular abnormalities induced by diabetes. The Affymetrix GeneChip Rat Genome 230 2.0 array was complemented by real-time RT-PCR, immunoblotting, and immunohistochemistry.
Results:
The retinal vessels of diabetic rats showed differential expression of 20 genes of the transforming growth factor (TGF)-beta pathway, in addition to genes involved in oxidative stress, inflammation, vascular remodeling, and apoptosis. The complete loop of TGF-beta signaling, including Smad2 phosphorylation, was enhanced in the retinal vessels, but not in the neural retina. Sorbinil normalized the expression of 71% of the genes related to oxidative stress and 62% of those related to inflammation. Aspirin had minimal or no effect on these two categories. The two drugs were instead concordant in reducing the upregulation of genes of the TGF-beta pathway (55% for sorbinil and 40% for aspirin) and apoptosis (74 and 42%, respectively).
Conclusions:
Oxidative and inflammatory stress is the distinct signature that the polyol pathway leaves on retinal vessels. TGF-beta and apoptosis are, however, the ultimate targets to prevent the capillary demise in diabetic retinopathy.
Insights
Diabetic retinopathy involves oxidative stress and inflammation, primarily impacting retinal vessels. Transforming growth factor-beta (TGF-beta) and apoptosis are key targets for preventing capillary damage.
Area of Science:
- Ophthalmology
- Diabetology
- Molecular Biology
Background:
- Diabetic retinopathy (DR) is a leading cause of vision loss, driven by hyperglycemia's effects on retinal vasculature.
- Identifying molecular targets is crucial for developing drugs to prevent DR progression.
Purpose of the Study:
- To investigate molecular changes in retinal vessels of diabetic rats.
- To identify potential drug targets for preventing diabetic retinopathy by examining the effects of sorbinil and aspirin.
Main Methods:
- Gene expression profiling of retinal vessels from diabetic and control rats.
- Analysis of transforming growth factor-beta (TGF-beta) signaling, oxidative stress, inflammation, and apoptosis.
- Validation using real-time RT-PCR, immunoblotting, and immunohistochemistry.
Main Results:
- Diabetic rats exhibited altered expression of TGF-beta pathway genes, oxidative stress, inflammation, and apoptosis markers in retinal vessels.
- Sorbinil effectively normalized oxidative stress and inflammation-related gene expression.
- Both sorbinil and aspirin reduced TGF-beta pathway and apoptosis-related gene upregulation.
Conclusions:
- The polyol pathway significantly contributes to oxidative and inflammatory stress in diabetic retinal vessels.
- Targeting TGF-beta signaling and apoptosis pathways holds promise for preventing diabetic retinopathy.
Related Concept Videos
TGF - β Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Diabetic Retinopathy
Regulation of Angiogenesis and Blood Supply
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
